Jun 10, 2020
BryoLogyx Announces Agreements with Neurotrope to Acquire Bryostatin-1 Immuno-Oncology Data Package, Supply Synthetic Bryostatin-1
May 26, 2020
Neurotrope Announces Investor Update Conference Call
Jan 22, 2020
Neurotrope, Inc. Announces $18 Million Registered Direct Offering
Jan 22, 2020
Neurotrope Provides Corporate Update After Completing Bryostatin-1 Data Analysis for Advanced Alzheimer's Disease Trial
Oct 08, 2019
Neurotrope Announces Review of Strategic Alternatives to Maximize Shareholder Value
Sep 09, 2019
Neurotrope Announces Top-line Results From Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease
Aug 13, 2019
Neurotrope Announces Publication Highlighting the Potential of Bryostatin as a Unique Neurorestorative Therapy
Aug 05, 2019
Neurotrope Announces Corporate Update and Reports Second Quarter 2019 Financial Results
Jul 15, 2019
Neurotrope Concludes Data Collection in Confirmatory Phase 2 Clinical Trial of Moderately Severe to Severe Alzheimer's Disease
Jul 11, 2019
Neurotrope to Present at the Alzheimer's Association International Conference; Neurotrope President and Chief Scientific Officer, Dr. Daniel L. Alkon, to Receive Cure Coin Award; Design of Confirmatory Phase 2 Trial to be Presented
Jun 03, 2019
Neurotrope's President and Chief Scientific Officer to Present at the Alzheimer's Solutions Conference at The University of the Sciences in Philadelphia, PA on June 3rd, 2019
May 30, 2019
Neurotrope to Present at the LD Micro 9th Annual Invitational Conference on June 4, 2019
Apr 19, 2019
Neurotrope Announces Inducement Grant to Newly-Appointed Chief Operating Officer and General Counsel
Apr 01, 2019
Neurotrope Appoints Dr. Michael Ciraolo As General Counsel And Chief Operating Officer
Mar 21, 2019
Neurotrope Comments On Biogen's Discontinued Phase 3 Trial In Alzheimer's Disease
Mar 13, 2019
Neurotrope Completes Enrollment Of Confirmatory Phase 2 Study of Bryostatin-1 in Moderate to Severe Alzheimer's Disease
Mar 11, 2019
Neurotrope Reports Year End 2018 Financial Results
Feb 08, 2019
Neurotrope to Participate in the BIO CEO & Investor Conference
Feb 04, 2019
Neurotrope Announces Cooperative Research and Development Agreement for Bryostatin-1 with the National Cancer Institute
Jan 03, 2019
Neurotrope to Participate in the Sachs Associates 2nd Annual Neuroscience Innovation Forum